SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-15-131510
Filing Date
2015-04-15
Accepted
2015-04-15 17:25:37
Documents
5
Period of Report
2015-05-19
Effectiveness Date
2015-04-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A d905716ddef14a.htm DEF 14A 298125
2 GRAPHIC g905716g74u23.jpg GRAPHIC 9097
3 GRAPHIC g905716stamp3a.jpg GRAPHIC 7165
4 GRAPHIC g905716stamp3b.jpg GRAPHIC 8624
5 GRAPHIC g905716stamp4.jpg GRAPHIC 7201
  Complete submission text file 0001193125-15-131510.txt   343991
Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Filer) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35945 | Film No.: 15772647
SIC: 2834 Pharmaceutical Preparations